查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1914152

磁粒子成像设备市场按产品类型、应用、通路和最终用户划分－2026-2032年全球预测

Magnetic Particle Imaging Device Market by Product Type, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年磁粒子成像设备市值为1.6526亿美元，预计2026年将成长至1.9049亿美元，复合年增长率为16.48%，到2032年将达到4.8092亿美元。

关键市场统计数据
基准年 2025 1.6526亿美元
预计年份：2026年 1.9049亿美元
预测年份 2032 4.8092亿美元
复合年增长率 (%) 16.48%

简要介绍磁粒子成像（MPI）的技术特性、潜在应用和不断发展的设备生态系统

磁粒子成像（MPI）是一种快速发展的成像技术，它利用超顺磁性氧化铁奈米粒子的特异性磁响应，无需电离辐射即可产生高灵敏度、高对比度的影像。与依赖衰减或质子弛豫的现有临床成像技术不同，MPI 直接检测示踪剂的磁化强度，从而提供针对特定奈米粒子造影剂的即时讯号。这项技术特性为广泛的潜在临床和研究应用奠定了基础，涵盖血管成像到临床前肿瘤学研究中的靶向示踪追踪等领域。

仪器研发、示踪剂创新和合作研究路径的新转折点正在重塑磁粒子成像技术，使其从研究走向临床实践。

随着技术的成熟、临床需求的成长以及监管机构的积极参与，磁粒子成像（MPI）领域正经历着一场变革性的转变。 MPI最初仅限于一些专业的临床前研究团队，如今已吸引了许多设备创新者的广泛关注，他们致力于开发针对特异性器官的临床系统以及全身成像系统。这项转变的驱动力主要来自示踪剂化学技术的进步，这些进步提高了讯号保真度和生物相容性；以及演算法的进步，这些进步加速了影像重建并减少了伪影。

评估近期美国关税调整对成像设备开发商的采购、製造策略和供应链韧性的影响

美国政策环境的调整导致进口先进诊断影像设备所需的专用零件和材料受到关税影响。这些变化使得从国际市场采购磁场发生硬体、电力电子元件和精密运动部件的企业面临更复杂的成本环境。因此，设备开发商及其供应商正在重新调整筹资策略，以降低关税波动带来的风险，同时保持供应链的稳健性。

详细的細項分析重点阐述了产品类型、应用、分销管道和终端用户趋势对设备策略和采用率的影响。

了解细分市场的细微差别有助于我们了解磁粒子成像技术拓展的多种途径，以及针对不同使用者需求的价值累积领域。根据产品类型，市场可分为临床系统和临床前系统。临床产品可进一步细分为针对特定器官的高解析度成像系统（旨在局部应用）和全身成像系统（旨在拓展适应症并促进临床应用）。临床前平台则分为连结转化研究的大型动物系统和针对高通量实验室研究最佳化的小型动物系统，两者分别满足不同的实验和检验需求。

区域趋势和跨国合作将影响MPI所采取的监管路径、临床检验地点和区域生产策略。

地理动态在磁粒子成像技术的应用路径和商业策略中发挥着至关重要的作用，因为区域生态系统塑造着监管路径、临床合作和供应链结构。在美洲，临床研究中心和先进的转化医学中心推动早期临床可行性研究，加上设备创新者和学术医疗中心的聚集，加速了多学科检验。这种环境支援设备的迭代改进，并促进了产业界与临床研究人员之间的伙伴关係。

绘製竞争格局图：视觉化硬体创新者、追踪专家和策略伙伴如何合作推动MPI商业化

磁粒子成像 (MPI) 产业格局涵盖了成熟的成像公司、专注于 MPI 硬体或示踪剂化学的专业新创公司，以及能够实现规模化生产的契约製造製造商。成熟的影像供应商提供Start-Ups专业知识、临床工作流程整合能力和成熟的商业管道，并可透过捆绑式解决方案和现有客户关係加速临床应用。同时，Start-Ups往往是线圈设计、低噪音电子元件和奈米粒子工程领域快速创新的源泉，它们经常与学术团队合作，在受控的临床前环境中检验新方法。

开发商和相关人员可以采取哪些切实可行的策略步骤来加速MPI临床检验、保障供应链并优化上市流程？

产业领导者可以透过优先进行一系列合作行动，使技术开发与临床需求和商业性现实相契合，从而加速磁粒子成像技术的临床应用和广泛推广。首先，投资于示踪剂和设备的共同开发项目，以同时优化奈米粒子配方和扫描器参数。这将缩短迭代周期，并增强临床应用的合理性。其次，制定临床检验路径，从器官特异性可行性研究入手，逐步推进至更广泛的临床应用，进而在控制证据风险的同时拓展适应症。这种分阶段的方法将有助于更清楚地进行医保报销谈判，并实现对临床效用的精准论证。

采用综合性的混合研究途径，结合相关人员访谈、技术检验和系统性的二手资料研究，确保研究结果的可靠性。

本报告的调查方法结合了定性研究和来自技术和监管文献的定量三角验证。定性研究包括对设备工程师、示踪剂科学家、临床研究人员、医院和研究机构的采购人员以及分销合作伙伴进行结构化访谈，以收集有关技术要求、实施障碍和服务期望的第一手资讯。这些访谈辅以技术检验，该工作包括审查与造影剂和诊断影像设备相关的同行评审文章、临床前试验通讯协定和监管指导文件。

关于如何协调技术、监管和商业性实施，从而将磁粒子成像的潜力转化为持续的临床和研究影响的策略性结论

磁粒子成像技术正处于一个关键的转折点，其成熟的技术优势、日益增长的临床应用需求以及与规模化生产、监管合规和供应链优化相关的实际挑战交织在一起。该技术固有的示踪讯号特异性和即时定量成像潜力，为标靶临床应用和转化研究提供了明确的价值提案，能够连接实验室研究和患者研究。然而，其应用的速度和模式将取决于开发人员如何有效地解决与现有工作流程的整合、针对特定适应症的证据产生以及医疗系统和研究客户的营运需求等问题。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：磁粒子成像设备市场（依产品类型划分）

  • 临床应用
    • 器官特异性
    • 全身
  • 临床前
    • 大型动物
    • 小动物

第九章 磁粒子成像设备市场（依应用领域划分）

  • 临床诊断
    • 心血管影像
    • 神经影像学
  • 临床前研究
    • 心血管调查
    • 肿瘤学
      • 转移检测
      • 肿瘤影像

第十章 磁粒子成像设备市场（依通路划分）

  • 直销
    • 现场销售
    • 线上销售
  • 经销商
    • OEM合作伙伴
    • 第三者

第十一章：依最终用户分類的磁粒子成像设备市场

  • 医院
    • 私人诊所
    • 公立医院
  • 研究所
    • 学术机构
    • 政府

第十二章：磁粒子成像设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：磁粒子成像设备市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国磁力粒子成像设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国磁力粒子成像设备市场

第十六章 中国磁粒子影像设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aspect Imaging Ltd.
  • Bayer AG
  • BMG LABTECH GmbH
  • Bruker BioSpin GmbH
  • Danfoss A/S
  • I'rom Pharmaceutical Co., Ltd.
  • Koninklijke Philips NV
  • Magnetic Insight, Inc.
  • MILabs BV
  • Mitsubishi Electric
  • Siemens Healthineers AG
Product Code: MRR-AE420CB13B4F

The Magnetic Particle Imaging Device Market was valued at USD 165.26 million in 2025 and is projected to grow to USD 190.49 million in 2026, with a CAGR of 16.48%, reaching USD 480.92 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 165.26 million
Estimated Year [2026] USD 190.49 million
Forecast Year [2032] USD 480.92 million
CAGR (%) 16.48%

A concise introduction to magnetic particle imaging outlining its technical distinctiveness, translational promise, and evolving device ecosystem

Magnetic Particle Imaging (MPI) represents a rapidly maturing imaging modality that leverages the unique magnetic response of superparamagnetic iron oxide nanoparticles to generate high-sensitivity, high-contrast images without ionizing radiation. Unlike established clinical modalities that rely on attenuation or proton relaxation, MPI directly detects tracer magnetization, delivering a real-time signal that is inherently specific to the administered nanoparticle contrast agent. This technical distinction underpins a range of potential clinical and research applications, from vascular imaging to targeted tracer tracking in preclinical oncology studies.

Early adopters in preclinical laboratories have demonstrated MPI's ability to visualize tracer dynamics with temporal resolution suited to perfusion and functional studies, while organ-specific device designs and whole-body system concepts are progressing through prototype and regulatory pathways. As a result, MPI is transitioning from a primarily investigational technique to a platform with emerging translational trajectories. The device ecosystem spans benchtop preclinical scanners optimized for small and large animal models, organ-focused clinical prototypes engineered for high-resolution target imaging, and evolving whole-body concepts intended to broaden clinical utility.

Technical innovation continues to be driven by advances in nanoparticle engineering, scanner architecture, and reconstruction algorithms. These developments have reduced some historical limitations around spatial resolution and sensitivity, while enabling lower tracer doses and faster acquisition times. At the same time, integration with complementary imaging modalities and compatible workflows is becoming a priority for clinical translation, prompting cross-disciplinary collaborations among imaging physicists, materials scientists, device engineers, and clinical investigators. Consequently, decision makers must weigh technical maturity, regulatory strategy, and operational integration when considering MPI adoption.

Emerging inflection in device development, tracer innovation, and collaborative pathways that are reshaping magnetic particle imaging from research to clinical practice

The landscape for magnetic particle imaging is undergoing transformative shifts as technical maturation aligns with growing clinical interest and regulatory engagement. Initially concentrated within specialized preclinical research groups, MPI is now attracting broader attention from device innovators pursuing both organ-specific clinical systems and whole-body form factors. This transition is being catalyzed by improvements in tracer chemistry, which have enhanced signal fidelity and biocompatibility, and by algorithmic advances that accelerate image reconstruction while reducing artifacts.

In parallel, strategic partnerships across academia, early-stage industry players, and larger medical device organizations are reshaping development pathways. These collaborations facilitate rapid iteration of hardware designs, validation studies across diverse biological models, and coordinated submissions for clinical feasibility trials. Importantly, the role of complementary modalities such as MRI and ultrasound is becoming more prominent, with hybrid workflows and data fusion approaches enabling richer diagnostic interpretation and clinical decision support. The shift toward integrated imaging strategies reinforces the necessity of interoperability standards, reproducible protocols, and robust tracer supply chains.

From a deployment perspective, the device footprint and cost profile are evolving alongside user requirements. Organ-specific devices aim to deliver high-resolution imaging with compact installations suitable for specialty centers, whereas whole-body ambitions seek to broaden clinical indications but face more stringent infrastructural and reimbursement considerations. As a result, stakeholders must adopt flexible development and commercialization strategies that accommodate phased clinical evidence generation, differentiated product tiers, and targeted market entry points. Taken together, these dynamics signal an inflection point in which MPI moves from niche research tool toward a clinically relevant imaging option, contingent on coordinated progress across technology, regulation, and clinical validation.

Assessing how recent tariff adjustments in the United States are altering procurement, manufacturing strategy, and supply chain resilience for imaging device developers

The policy environment in the United States has introduced tariff adjustments that affect the importation of specialized components and materials integral to advanced imaging device manufacturing. These changes create a more complex cost environment for firms that source field-generating hardware, power electronics, and precision motion components internationally. Consequently, device developers and their suppliers are recalibrating procurement strategies to mitigate exposure to variable duties while preserving supply chain resilience.

In response, multiple manufacturers have begun to diversify their supplier base, prioritize onshoring of critical subsystems where economically viable, and renegotiate long-term agreements with partners capable of absorbing some tariff volatility. At the same time, the tariffs have incentivized vertical integration in specific segments of the value chain, particularly for companies seeking to secure access to high-quality drive coils, gradient amplifiers, and tracer formulation materials. These strategic moves are coupled with cost modeling that factors in potential duty fluctuations, logistics lead times, and inventory positioning to sustain development timelines.

Beyond procurement, regulatory and clinical trial planning is being adapted to account for potential delays in component availability and increased unit costs for prototype and clinical systems. Organizations pursuing accelerated translation are assessing manufacturing strategies that balance domestic production, contract manufacturing in tariff-favorable jurisdictions, and strategic inventory buffers. For purchasers and health systems, procurement decisions now weigh not only device capabilities but also demonstrated supply continuity and long-term serviceability. Ultimately, while tariffs introduce short- to medium-term headwinds to cost structures, they are also prompting strategic supply-chain redesigns that can yield greater control over quality and delivery reliability across the device lifecycle.

In-depth segmentation analysis revealing how product type, application, distribution channels, and end-user dynamics influence device strategy and adoption

A nuanced understanding of segmentation clarifies the diverse pathways through which magnetic particle imaging can scale and where value accrues across different user needs. Based on product type, the market bifurcates into clinical and preclinical systems. Clinical offerings can be further differentiated by organ-specific designs that target localized, high-resolution applications and by whole-body systems that aim to broaden indication sets and institutional adoption. Preclinical platforms break down into large animal systems that bridge translational studies and small animal systems optimized for high-throughput laboratory research, each addressing distinct experimental and validation requirements.

Application-based segmentation highlights how clinical diagnosis and preclinical research drive device and tracer requirements differently. Clinical diagnostic use cases include cardiovascular imaging that demands rapid temporal resolution and vascular specificity, as well as neurological imaging where localized tracer delivery and sensitivity to small-volume distribution patterns are paramount. Preclinical research applications emphasize cardiovascular research workflows that probe perfusion and device-tissue interactions and oncology studies where tracer behavior is monitored for tumor imaging and metastasis detection. Within oncology, capabilities that facilitate metastasis detection and high-contrast tumor imaging are especially valued for translational research and targeted therapeutic development.

Distribution channel segmentation informs go-to-market and support models, with direct sales channels encompassing field-based engagement and digital sales pathways tailored to complex capital equipment. Field sales enable onsite demonstration, clinical workflow integration assistance, and relationship-driven procurement, while online sales support streamlined procurement for standardized or lower-complexity platforms. Distributor networks include OEM partnerships that embed MPI capabilities within broader imaging suites and third-party distributors who extend geographic reach and localized service capabilities. End-user segmentation delineates hospitals and research institutes as primary customers. Hospitals require device designs compatible with private clinic workflows and public hospital procurement and service standards, whereas research institutes include academic and government laboratories that prioritize reproducibility, modularity, and research-focused support packages.

Taken together, these segmentation perspectives shape product design, regulatory planning, and commercialization strategies. They also influence the types of evidence and service models purchasers will expect, from longitudinal clinical studies for organ-specific clinical devices to flexible research agreements and reagent supply models for preclinical systems. Therefore, a coherent product and market approach must align technical specifications, distribution choices, and support offerings with the distinct expectations of each segment.

Regional dynamics and cross-border collaboration that determine regulatory routes, clinical validation hubs, and localized manufacturing strategies for MPI adoption

Geographic dynamics play a pivotal role in the adoption trajectory and commercial strategy for magnetic particle imaging technologies, with regional ecosystems shaping regulatory pathways, clinical engagement, and supply chain configurations. In the Americas, clinical research hubs and advanced translational centers drive early clinical feasibility studies, complemented by a concentration of device innovators and academic medical centers that can accelerate multidisciplinary validation. This environment supports iterative device refinement and fosters partnerships that bridge industry and clinical investigators.

In Europe, Middle East & Africa, regulatory harmonization initiatives and strong translational research networks contribute to structured clinical evaluation pathways. Regional centers of excellence, often affiliated with major universities and public research institutes, are pivotal for demonstrating modality-specific advantages in targeted indications. Market access strategies in these jurisdictions emphasize robust clinical evidence and alignment with regional reimbursement mechanisms. In the Asia-Pacific region, rapid investments in research infrastructure and a growing appetite for advanced imaging technologies are driving significant interest in both preclinical and clinical MPI applications. Local manufacturers and research consortia are active in developing tracer chemistry, scanner designs adapted to regional clinical workflows, and localized service ecosystems to support deployment at scale.

Across all regions, cross-border collaboration and multi-center studies are increasingly common, enabling comparative validation and standardization. Nonetheless, regional differences in regulatory expectations, procurement practices, and clinical priorities necessitate tailored engagement plans. For device developers and suppliers, regional strategy should account for the relative strength of research communities, pathways for regulatory clearance or approval, and the maturity of domestic manufacturing and service capabilities to ensure sustainable market entry and expansion.

Mapping the competitive ecosystem to highlight how hardware innovators, tracer specialists, and strategic partners combine to drive MPI commercialization

The company landscape for magnetic particle imaging encompasses established imaging firms, specialized startups focused exclusively on MPI hardware or tracer chemistry, and contract manufacturers that enable scalable production. Established imaging suppliers contribute systems engineering expertise, clinical workflow integration capabilities, and established commercial channels that can accelerate clinical translation through bundled solutions and existing customer relationships. In contrast, startups are frequently the source of rapid innovation in coil design, low-noise electronics, and nanoparticle engineering, and they often collaborate with academic groups to validate novel approaches in controlled preclinical settings.

Strategic partnerships are a recurring theme among industry participants, enabling complementary capabilities to be combined into more compelling propositions. For example, hardware-focused companies commonly partner with tracer developers to optimize signal characteristics and with algorithm providers to enhance reconstruction and quantitative analysis. Contract manufacturers and service partners play a critical role in scaling production, ensuring traceability and quality control for contrast agents, and supporting aftermarket service contracts that are essential for clinical adopters. Investors and strategic acquirers are monitoring proof-of-concept clinical studies and regulatory milestones as signals for downstream consolidation opportunities.

Competitive dynamics are shaped by technical differentiation, intellectual property around nanoparticle formulations and scanner components, and the ability to demonstrate reproducible clinical or preclinical results. As clinical evidence accumulates, collaboration opportunities with larger medical device companies or diagnostic imaging networks are likely to increase, presenting pathways for accelerated commercialization and broader market access. For industry observers and potential partners, evaluating the capability mix-ranging from hardware design and manufacturing to tracer chemistry and clinical trial execution-is central to forming effective alliances and investment decisions.

Actionable strategic steps for developers and stakeholders to accelerate clinical validation, secure supply chains, and optimize go-to-market execution for MPI

Industry leaders can accelerate translation and adoption of magnetic particle imaging by prioritizing a set of coordinated actions that align technical development with clinical needs and commercial realities. First, invest in tracer-device co-development programs to ensure that nanoparticle formulations and scanner parameters are optimized in tandem; this reduces iteration cycles and strengthens the clinical case for adoption. Second, structure clinical validation pathways that begin with organ-specific feasibility studies and progress to broader clinical implementations, thereby managing evidence risk while expanding potential indications. These phased approaches support clearer reimbursement dialogues and enable targeted demonstration of clinical utility.

Third, build resilient supply chains that combine domestic production capabilities for critical subsystems with diversified international partnerships for components where onshoring is not feasible. This approach mitigates exposure to tariff volatility and logistics disruptions while preserving cost competitiveness. Fourth, create flexible distribution and service models that reflect segmentation realities: field-based clinical engagement for organ-specific devices, and scalable service architectures for preclinical systems used across academic and government laboratories. Finally, engage early with regulatory bodies and reimbursement stakeholders to clarify evidence requirements and to design studies that address decision-maker priorities. By implementing these actions, organizations can reduce commercialization friction, enhance stakeholder confidence, and position their offerings for accelerated adoption in both research and clinical settings.

Comprehensive mixed-method research approach combining stakeholder interviews, technical validation, and systematic secondary analysis to ensure robust insights

The research methodology underpinning this report integrates primary qualitative engagement with quantitative triangulation from technical literature and regulatory documentation. Primary research comprised structured interviews with device engineers, tracer scientists, clinical investigators, procurement leaders at hospitals and research institutes, and distribution partners to capture first-hand perspectives on technical requirements, adoption barriers, and service expectations. These interviews were complemented by technical validation exercises that reviewed peer-reviewed publications, preclinical study protocols, and regulatory guidance documents relevant to contrast agents and imaging devices.

Secondary analysis drew on a systematic review of scientific literature, patent filings, conference proceedings, and public regulatory submissions to characterize technological trajectories in nanoparticle formulation, coil and drive architectures, and reconstruction algorithm advances. Where possible, insights were cross-referenced across multiple sources to validate trends and to identify consensus or divergence among stakeholders. The methodology also incorporated scenario planning to assess the implications of supply chain disruptions, policy shifts, and differential regional regulatory timelines. Throughout, data integrity was maintained via source attribution and methodological transparency, and uncertainty was explicitly acknowledged where evidence was emergent or where competitive information remained confidential.

A strategic conclusion on how coordinated technical, regulatory, and commercial execution can convert magnetic particle imaging's potential into sustained clinical and research impact

Magnetic particle imaging stands at a pivotal juncture where demonstrated technical advantages and growing clinical interest converge with practical challenges related to scaling, regulatory alignment, and supply-chain optimization. The modality's intrinsic specificity to tracer signals and its potential for real-time quantitative imaging provide clear value propositions for targeted clinical applications and for translational research that bridges lab and patient studies. However, the pace and shape of adoption will be determined by how effectively developers address integration with existing workflows, evidence generation for specific indications, and the operational requirements of health systems and research customers.

Forward-looking organizations will be those that integrate tracer and device development, pursue strategic partnerships to de-risk supply and manufacturing, and design regulatory and clinical programs that progressively expand clinical credibility while managing resource commitments. Regional strategies should be informed by local regulatory landscapes and research capabilities, and distribution models must align with the expectations of hospitals and research institutions. With coordinated execution across these domains, magnetic particle imaging can move from promising technological concept to a reliable clinical and research tool that complements existing modalities and opens new avenues for precision diagnostics and therapeutic monitoring.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Particle Imaging Device Market, by Product Type

  • 8.1. Clinical
    • 8.1.1. Organ Specific
    • 8.1.2. Whole Body
  • 8.2. Preclinical
    • 8.2.1. Large Animal
    • 8.2.2. Small Animal

9. Magnetic Particle Imaging Device Market, by Application

  • 9.1. Clinical Diagnosis
    • 9.1.1. Cardiovascular Imaging
    • 9.1.2. Neurological Imaging
  • 9.2. Preclinical Research
    • 9.2.1. Cardiovascular Research
    • 9.2.2. Oncology
      • 9.2.2.1. Metastasis Detection
      • 9.2.2.2. Tumor Imaging

10. Magnetic Particle Imaging Device Market, by Distribution Channel

  • 10.1. Direct Sales
    • 10.1.1. Field Sales
    • 10.1.2. Online Sales
  • 10.2. Distributors
    • 10.2.1. OEM Partners
    • 10.2.2. Third Party

11. Magnetic Particle Imaging Device Market, by End User

  • 11.1. Hospitals
    • 11.1.1. Private Clinics
    • 11.1.2. Public Hospitals
  • 11.2. Research Institutes
    • 11.2.1. Academic
    • 11.2.2. Government

12. Magnetic Particle Imaging Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Magnetic Particle Imaging Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Magnetic Particle Imaging Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Magnetic Particle Imaging Device Market

16. China Magnetic Particle Imaging Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aspect Imaging Ltd.
  • 17.6. Bayer AG
  • 17.7. BMG LABTECH GmbH
  • 17.8. Bruker BioSpin GmbH
  • 17.9. Danfoss A/S
  • 17.10. I'rom Pharmaceutical Co., Ltd.
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Magnetic Insight, Inc.
  • 17.13. MILabs B.V.
  • 17.14. Mitsubishi Electric
  • 17.15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ORGAN SPECIFIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ORGAN SPECIFIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ORGAN SPECIFIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY WHOLE BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY WHOLE BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY WHOLE BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY LARGE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY LARGE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SMALL ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SMALL ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY NEUROLOGICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY NEUROLOGICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY METASTASIS DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY METASTASIS DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY METASTASIS DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY TUMOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY TUMOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY TUMOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY FIELD SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY FIELD SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY FIELD SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY OEM PARTNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY OEM PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY OEM PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY THIRD PARTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY THIRD PARTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 221. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 224. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 225. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 228. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 231. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 263. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 266. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 267. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 270. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 273. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 274. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 280. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 281. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 283. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 284. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 287. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 288. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARK